Insights

European MidPharmas are a class of companies that Novasecta has been specialising in since its foundation. These R&D-based pharmaceutical companies with annual revenues of €50m to €5bn are tremendously diverse, just like the European countries in which they are based. Working closely with these companies for over a decade has provided us with a substantial body of insight into how these companies and their larger and smaller competitors can sustainably grow and improve performance.

To view the contents of this post, please submit your email address and you will gain access to all posts on our web site...






Click here if you would like to receive emails from us. Read our privacy policy

To receive details of new white papers and events please enter your details below

Click here if you would like to receive emails from us. Read our privacy policy

Newsletter Signup